Study Subject Medical Information Sample Clauses

Study Subject Medical Information. The Sponsor may access the Study Materials during regular business hours, upon reasonable advance notice to the Institution/Principal Investigator. The Sponsor shall comply with Applicable Law regarding the confidentiality of Study Subjects’ medical records and other health information, shall hold the Study Subjects’ personal identifying information in confidence, and shall act in accordance with the Informed Consents. Subject to the foregoing, the Sponsor may copy Institution/Principal Investigator records containing such information to the extent permitted by Applicable Law and the express authorization of Informed Consents 2.3 Zdravotné údaje účastníkov klinického skúšania. Zadávateľ bude mať prístup k materiálom skúšania v bežnej pracovnej dobe po oznámení inštitúcii/zodpovednému skúšajúcemu v primeranom predstihu. Zadávateľ musí dodržiavať platné právne predpisy týkajúce sa dôvernosti zdravotných xxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx a ďalších zdravotných údajov, musí uchovávať v dôvernosti informácie umožňujúce osobnú identifikáciu účastníkov a musí konať v súlade s informovaným súhlasom. V súlade s vyššie uvedeným môže zadávateľ vytvárať kópie záznamov inštitúcie/zodpovedného skúšajúceho obsahujúce takéto informácie v rozsahu povolenom platnými právnymi from relevant Study Subjects. Institution/Principal Investigator acknowledges that Sponsor may disclose Study Materials to its drug development partners, other clinical investigators in the Study, the FDA, the EMEA, and foreign regulatory agencies. predpismi a výslovným povolením v informovanom súhlase príslušných účastníkov klinického skúšania. Inštitúcia/zodpovedný skúšajúci uznávajú, že zadávateľ môže poskytnúť materiály skúšania svojim partnerom pri vývoji lieku, ďalším klinickými skúšajúcim v klinickom skúšaní, agentúre FDA, agentúre EMEA a zahraničným regulačným orgánom.
Sample 1See All (5)
AutoNDA by SimpleDocs
Study Subject Medical Information. The Sponsor may access the Study Materials during regular business hours, upon reasonable advance notice to the Institution. The Sponsor shall comply with Applicable Law regarding the confidentiality of Study Subjects’ medical records and other health information, shall hold the Study Subjects’ personal identifying information in confidence, and shall act in accordance with the Informed Consents. Subject to the foregoing, the Sponsor may copy Institution records containing such information to the extent permitted by Applicable Law and the express authorization of Informed Consents from relevant Study Subjects. Institution acknowledges that Sponsor may disclose Study Materials to its drug development partners, other clinical investigators in the Study, the FDA and other competent regulatory agencies. During monitoring/auditing, the legal obligations of the Institution shall be 2.3 Zdravotní informace subjektů studie. Zadavatel může mít přístup k materiálům studie během běžné pracovní doby, na základě přiměřeného předchozího oznámení zdravotnickému zařízení. Zadavatel bude dodržovat požadavky příslušných zákonů, které se týkají důvěrnosti zdravotních záznamů subjektů studie a jiných zdravotních informací, bude zachovávat důvěrnost informací subjektů studie, které umožňují jejich osobní identifikaci, a bude jednat v souladu s informovanými souhlasy. Za výše uvedených podmínek může zadavatel kopírovat záznamy zdravotnického zařízení, které obsahují tyto informace, v rozsahu povoleném příslušnými zákony a odpovídajícím oprávnění v informovaných souhlasech od příslušných subjektů studie. Zdravotnické zařízení bere na vědomí, že zadavatel může zpřístupnit materiály studie svým partnerům xxx xxxxxx xxxxxx, xxxxxxxx xxxxxxxxx zkoušejícím v rámci studie, úřadu FDA a jiným příslušným kontrolním úřadům. V rámci monitorování/auditu budou respected, especially the obligation of confidentiality and personal data protection, as well as protection of trade secrets of the Institution. The Sponsor shall be responsible for compliance with confidentiality requirements relating to such information of persons performing the audit. Access for monitoring/auditing purposes shall be allowed only into rooms in which the clinical trial is conducted. After the completion of the Study, the Sponsor shall be entitled to enter only into the rooms designated by the Institution for the purpose of inspection of the documentation related to the Study. respektovány zákonné povinnosti zdravotnic...
Sample 1
Study Subject Medical Information. The Sponsor may access the Study Documents during regular business hours, upon reasonable advance notice to the Institution/Principal Investigator. The Sponsor shall comply with Applicable Law regarding the confidentiality of Study Subjects’ medical records and other health information, shall hold the Study Subjects’ personal identifying information in confidence, and shall act in accordance with the Informed Consents and the HIPAA Authorizations (as defined in Section 9.5). Subject to the foregoing, the Sponsor may 2.
Sample 1

Related to Study Subject Medical Information

  • Medical Information Throughout the Pupil's time as a member of the School, the School Medical Officer shall have the right to disclose confidential information about the Pupil if it is considered to be in the Pupil's own interests or necessary for the protection of other members of the School community. Such information will be given and received on a confidential, need-to-know basis.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Confidential Information and Inventions (a) The Executive recognizes and acknowledges that in the course of his duties he is likely to receive confidential or proprietary information owned by the Company, its affiliates or third parties with whom the Company or any such affiliates has an obligation of confidentiality. Accordingly, during and after the Term, the Executive agrees to keep confidential and not disclose or make accessible to any other person or use for any other purpose other than in connection with the fulfillment of his duties under this Agreement, any Confidential and Proprietary Information (as defined below) owned by, or received by or on behalf of, the Company or any of its affiliates. “Confidential and Proprietary Information” shall include, but shall not be limited to, business plans (both current and under development), client lists, promotion and marketing programs, trade secrets, or any other confidential or proprietary business information relating to business operations of the Company The Executive expressly acknowledges the trade secret status of the Confidential and Proprietary Information and that the Confidential and Proprietary Information constitutes a protectable business interest of the Company. The Executive agrees: (i) not to use any such Confidential and Proprietary Information for himself or others; and (ii) not to take any Company material or reproductions (including but not limited to writings, correspondence, notes, drafts, records, invoices, technical and business policies, computer programs or disks) thereof from the Company’s offices at any time during his employment by the Company, except as required in the execution of the Executive’s duties to the Company. The Executive agrees to return immediately all Company material and reproductions (including but not limited, to writings, correspondence, notes, drafts, records, invoices, technical and business policies, computer programs or disks) thereof in his possession to the Company upon request and in any event immediately upon termination of employment. (b) Except with prior written authorization by the Company, the Executive agrees not to disclose or publish any of the Confidential and Proprietary Information, or business information of any other party to whom the Company or any of its affiliates owes an obligation of confidence, at any time during or after his employment with the Company.

  • INITIAL INFORMATION § 1.1 This Agreement is based on the Initial Information set forth in this Section 1.1. § 1.1.1 The Owner’s program for the Project:

  • Company Information Subscriber understands that the Company is subject to all the risks that apply to early-stage companies, whether or not those risks are explicitly set out in the Offering Circular. Subscriber has had such opportunity as it deems necessary (which opportunity may have presented through online chat or commentary functions) to discuss the Company’s business, management and financial affairs with managers, officers and management of the Company and has had the opportunity to review the Company’s operations and facilities. Subscriber has also had the opportunity to ask questions of and receive answers from the Company and its management regarding the terms and conditions of this investment. Subscriber acknowledges that except as set forth herein, no representations or warranties have been made to Subscriber, or to Subscriber’s advisors or representative, by the Company or others with respect to the business or prospects of the Company or its financial condition.

  • Confidential Information; Inventions (a) The Executive shall not disclose or use at any time, either during the Period of Employment or thereafter, any Confidential Information (as defined below) of which the Executive is or becomes aware, whether or not such information is developed by Executive, except to the extent that such disclosure or use is directly related to and required by the Executive’s performance in good faith of duties for the Company. The Executive will take all appropriate steps to safeguard Confidential Information in Executive’s possession and to protect it against disclosure, misuse, espionage, loss and theft. The Executive shall deliver to the Company at the termination of the Period of Employment, or at any time the Company may request, all memoranda, notes, plans, records, reports, computer tapes and software and other documents and data (and copies thereof) relating to the Confidential Information or the Work Product (as hereinafter defined) of the business of the Company or any of its Affiliates which the Executive may then possess or have under Executive’s control. Notwithstanding the foregoing, the Executive may truthfully respond to a lawful and valid subpoena or other legal process, but shall give the Company the earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought, and shall assist the Company and such counsel in resisting or otherwise responding to such process. Nothing in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. Executive does not need the prior authorization to make any such reports or disclosures and is not required to notify the Employer of such reports or disclosures. (b) As used in this Agreement, the term “Confidential Information” means information that is not generally known to the public and that is used, developed or obtained by the Company or its Affiliates in connection with their businesses, including, but not limited to, information, observations and data obtained by the Executive while employed by the Company or any predecessors thereof (including those obtained prior to the Effective Date) concerning (i) the business or affairs of the Company (or such predecessors), (ii) products or services, (iii) fees, costs and pricing structures, (iv) designs, (v) analyses, (vi) drawings, photographs and reports, (vii) computer software, including operating systems, applications and program listings, (viii) flow charts, manuals and documentation, (ix) data bases, (x) accounting and business methods, (xi) inventions, devices, new developments, methods and processes, whether patentable or unpatentable and whether or not reduced to practice, (xii) customers and clients and customer or client lists, (xiii) other copyrightable works, (xiv) all production methods, processes, technology and trade secrets, and (xv) all similar and related information in whatever form. Confidential Information will not include any information that has been published (other than a disclosure by the Executive in breach of this Agreement) in a form generally available to the public prior to the date the Executive proposes to disclose or use such information. Confidential Information will not be deemed to have been published merely because individual portions of the information have been separately published, but only if all material features comprising such information have been published in combination.

  • Contractor Information The Contractor will provide up to date information for each of the following in the form and manner specified by OGS:

  • Proprietary Information and Inventions You agree to execute, deliver and be bound by the provisions of the Proprietary Information and Inventions Agreement attached hereto as Exhibit C.

  • Third Party Confidential Information Consultant recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that at all times during the term of this Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential or proprietary information in the strictest confidence and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement with such third party.

  • Information Technology The following applies to all contracts for information technology commodities and contractual services. “Information technology” is defined in section 287.012(15), F.S., to have the same meaning as provided in section 282.0041, F.S.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!